LivaNova PLC (LIVN)
NASDAQ: LIVN · Real-Time Price · USD
47.59
+0.10 (0.21%)
Dec 20, 2024, 4:00 PM EST - Market closed
LivaNova Market Cap
LivaNova has a market cap or net worth of $2.58 billion as of December 20, 2024. Its market cap has increased by 6.43% in one year.
Market Cap
2.58B
Enterprise Value
2.92B
1-Year Change
6.43%
Ranking
Category
Stock Price
$47.59
Market Cap Chart
Since October 19, 2015, LivaNova's market cap has decreased from $3.42B to $2.58B, a decrease of -24.34%. That is a compound annual growth rate of -2.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 2.58B | -7.29% |
| Dec 29, 2023 | 2.79B | -6.24% |
| Dec 30, 2022 | 2.97B | -36.12% |
| Dec 31, 2021 | 4.65B | 44.63% |
| Dec 31, 2020 | 3.22B | -11.87% |
| Dec 31, 2019 | 3.65B | -18.02% |
| Dec 31, 2018 | 4.45B | 15.57% |
| Dec 29, 2017 | 3.85B | 75.67% |
| Dec 30, 2016 | 2.19B | -24.35% |
| Dec 31, 2015 | 2.90B | -15.10% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apogee Therapeutics | 2.68B |
| Vera Therapeutics | 2.66B |
| Neogen | 2.60B |
| Twist Bioscience | 2.59B |
| SpringWorks Therapeutics | 2.59B |
| Catalyst Pharmaceuticals | 2.56B |
| HUTCHMED (China) | 2.55B |
| Kymera Therapeutics | 2.53B |